Strand Therapeutics
Cambridge, United States· Est.
Strand Therapeutics is pioneering the development of programmable mRNA therapeutics for cancer immunotherapy and other diseases.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $198M
About
Strand Therapeutics is pioneering the development of programmable mRNA therapeutics for cancer immunotherapy and other diseases.
RNA TherapeuticsOncologyImmunology
Funding History
2Total raised:$198M
PIPE$153M
Series A$45M